FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2562127097> ?p ?o ?g. }

• W2562127097 endingPage "e000371" @default.
• W2562127097 startingPage "e000371" @default.
• W2562127097 abstract "<h3>Objective</h3> Clinical trials have not consistently demonstrated differences between tumour necrosis factor inhibitor (TNFi) plus methotrexate and triple therapy (methotrexate plus hydroxychloroquine plus sulfasalazine) in rheumatoid arthritis (RA). The study objective was to estimate the efficacy, radiographic benefits, safety and patient-reported outcomes of TNFi–methotrexate versus triple therapy in patients with RA. <h3>Methods</h3> A systematic review and network meta-analysis (NMA) of randomised controlled trials of TNFi–methotrexate or triple therapy as one of the treatment arms in patients with an inadequate response to or who were naive to methotrexate was conducted. American College of Rheumatology 70% response criteria (ACR70) at 6 months was the prespecified primary endpoint to evaluate depth of response. Data from direct and indirect comparisons between TNFi–methotrexate and triple therapy were pooled and quantitatively analysed using fixed-effects and random-effects Bayesian models. <h3>Results</h3> We analysed 33 studies in patients with inadequate response to methotrexate and 19 in patients naive to methotrexate. In inadequate responders, triple therapy was associated with lower odds of achieving ACR70 at 6 months compared with TNFi–methotrexate (OR 0.35, 95% credible interval (CrI) 0.19 to 0.64). Most secondary endpoints tended to favour TNFi–methotrexate in terms of OR direction; however, no clear increased likelihood of achieving these endpoints was observed for either therapy. The odds of infection were lower with triple therapy than with TNFi−methotrexate (OR 0.08, 95% CrI 0.00 to 0.57). There were no differences observed between the two regimens in patients naive to methotrexate. <h3>Conclusions</h3> In this NMA, triple therapy was associated with 65% lower odds of achieving ACR70 at 6 months compared with TNFi–methotrexate in patients with inadequate response to methotrexate. Although secondary endpoints numerically favoured TNFi–methotrexate, no clear differences were observed. The odds of infection were greater with TNFi–methotrexate. No differences were observed for patients naive to methotrexate. These results may help inform care of patients who fail methotrexate first-line therapy." @default.
• W2562127097 created "2017-01-06" @default.
• W2562127097 creator A5016296602 @default.
• W2562127097 creator A5020996416 @default.
• W2562127097 creator A5022181897 @default.
• W2562127097 creator A5023213876 @default.
• W2562127097 creator A5023265561 @default.
• W2562127097 creator A5035644440 @default.
• W2562127097 creator A5037938098 @default.
• W2562127097 creator A5046261111 @default.
• W2562127097 creator A5060524713 @default.
• W2562127097 creator A5070838723 @default.
• W2562127097 date "2017-01-01" @default.
• W2562127097 modified "2023-10-02" @default.
• W2562127097 title "Systematic review and network meta-analysis of the efficacy and safety of tumour necrosis factor inhibitor–methotrexate combination therapy versus triple therapy in rheumatoid arthritis" @default.
• W2562127097 cites W142190074 @default.
• W2562127097 cites W155548433 @default.
• W2562127097 cites W1590142646 @default.
• W2562127097 cites W1594638363 @default.
• W2562127097 cites W1721281419 @default.
• W2562127097 cites W1966425460 @default.
• W2562127097 cites W1966756501 @default.
• W2562127097 cites W1968024250 @default.
• W2562127097 cites W1969985421 @default.
• W2562127097 cites W1974402687 @default.
• W2562127097 cites W1979364075 @default.
• W2562127097 cites W1985763670 @default.
• W2562127097 cites W1988975600 @default.
• W2562127097 cites W1994065448 @default.
• W2562127097 cites W1996389186 @default.
• W2562127097 cites W1996437423 @default.
• W2562127097 cites W1996472975 @default.
• W2562127097 cites W1999543139 @default.
• W2562127097 cites W1999777294 @default.
• W2562127097 cites W2000962647 @default.
• W2562127097 cites W2005429018 @default.
• W2562127097 cites W2006566716 @default.
• W2562127097 cites W2009274084 @default.
• W2562127097 cites W2009298607 @default.
• W2562127097 cites W2024085618 @default.
• W2562127097 cites W2024737544 @default.
• W2562127097 cites W2028764755 @default.
• W2562127097 cites W2031184509 @default.
• W2562127097 cites W2035613798 @default.
• W2562127097 cites W2042620780 @default.
• W2562127097 cites W2046628605 @default.
• W2562127097 cites W2051986755 @default.
• W2562127097 cites W2053153138 @default.
• W2562127097 cites W2055934966 @default.
• W2562127097 cites W2057384628 @default.
• W2562127097 cites W2069016655 @default.
• W2562127097 cites W2069302785 @default.
• W2562127097 cites W2072599775 @default.
• W2562127097 cites W2076649628 @default.
• W2562127097 cites W2080506899 @default.
• W2562127097 cites W2082100198 @default.
• W2562127097 cites W2094872232 @default.
• W2562127097 cites W2095493602 @default.
• W2562127097 cites W2097341637 @default.
• W2562127097 cites W2098923148 @default.
• W2562127097 cites W2099046622 @default.
• W2562127097 cites W210061294 @default.
• W2562127097 cites W2101938343 @default.
• W2562127097 cites W2102100478 @default.
• W2562127097 cites W2105500082 @default.
• W2562127097 cites W2107542311 @default.
• W2562127097 cites W2108650270 @default.
• W2562127097 cites W2108779144 @default.
• W2562127097 cites W2109217002 @default.
• W2562127097 cites W2110205396 @default.
• W2562127097 cites W2111153776 @default.
• W2562127097 cites W2112753756 @default.
• W2562127097 cites W2113633952 @default.
• W2562127097 cites W2114229314 @default.
• W2562127097 cites W2116843833 @default.
• W2562127097 cites W2116996289 @default.
• W2562127097 cites W2117738981 @default.
• W2562127097 cites W2118704147 @default.
• W2562127097 cites W2120393706 @default.
• W2562127097 cites W2121050884 @default.
• W2562127097 cites W2125501404 @default.
• W2562127097 cites W2126275861 @default.
• W2562127097 cites W2126583816 @default.
• W2562127097 cites W2127011371 @default.
• W2562127097 cites W2130698927 @default.
• W2562127097 cites W2133147279 @default.
• W2562127097 cites W2134114605 @default.
• W2562127097 cites W2135461594 @default.
• W2562127097 cites W2139323151 @default.
• W2562127097 cites W2140219205 @default.
• W2562127097 cites W2140669143 @default.
• W2562127097 cites W2142056543 @default.
• W2562127097 cites W2142399236 @default.
• W2562127097 cites W2143212689 @default.
• W2562127097 cites W2143439165 @default.
• W2562127097 cites W2143972196 @default.
• W2562127097 cites W2147353090 @default.
• W2562127097 cites W2147975139 @default.

• next